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ABSTRACT
Transcription factor-induced lineage reprogram-
ming or transdifferentiation experiments are essen-
tial for understanding the plasticity of differentiated
cells. These experiments helped to define the
specific role of transcription factors in conferring
cell identity and played a key role in the develop-
ment of the regenerative medicine field. We here
investigated the acquisition of DNA methylation
changes during C/EBPa-induced pre-B cell to
macrophage transdifferentiation. Unexpectedly,
cell lineage conversion occurred without significant
changes in DNA methylation not only in key B cell-
and macrophage-specific genes but also through-
out the entire set of genes differentially methylated
between the two parental cell types. In contrast,
active and repressive histone modification marks
changed according to the expression levels of
these genes. We also demonstrated that C/EBPa
and RNA Pol II are associated with the methylated
promoters of macrophage-specific genes in reprog-
rammed macrophages without inducing methylation
changes. Our findings not only provide insights
about the extent and hierarchy of epigenetic
events in pre-B cell to macrophage transdiffer-
entiation but also show an important difference
to reprogramming towards pluripotency where
promoter DNA demethylation plays a pivotal role.
INTRODUCTION
The development of transcription factor-mediated cell
transdifferentiation strategies have played a fundamental
role to deﬁne the speciﬁc contribution of transcription
factors within a cell type, provide key information about
gene regulatory networks and facilitate new approaches
for the generation of custom designed cell types in
regenerative medicine (1).
The instructive role of transcription factors to specify
cell lineage was ﬁrst demonstrated when Weintraub’s team
reported that forced expression of MyoD in ﬁbroblasts
induces myotube formation (2). Since then, other factors
have proven their ability to induce transdifferentiation or
lineage reprogramming. For instance, GATA1 converts
monocytes into erythroid-megakaryocytic cells or eosino-
phils (3) and PU.1 converts erythroid-megakaryocytic
cells into myeloid cells (4). The most dramatic example
of transcription factor-mediated cell reprogramming can
be considered the generation of induced pluripotent stem
cells (iPSCs) from somatic cells by ectopic expression
of the transcription factors OCT4, SOX2, KLF4 and
MYC (5–9).
An excellent model for transcription factor-induced
lineage reprogramming is based on the ectopic expression
of C/EBPa in primary lymphoid cells. Enforced expres-
sion of C/EBPa by retroviral infection converts around
60% committed B-cell progenitors into functional
macrophages (10). Transdifferentiation is initiated by the
coordinated inhibition of Pax5 activity, resulting in
downregulation of CD19 and other B cell-speciﬁc genes,
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results in the activation of macrophage-speciﬁc genes.
Recently, a system based on a leukaemic pre-B cell line,
HAFTL, stably infected with an inducible form of
C/EBPa was developed. In this system, B cells undergo
100% conversion into macrophages within 2–3 days
after b-estradiol addition (11). The efﬁciency, tightness,
rapidity, stromal independence and availability of
unlimited cells make the system unique for investigating
the molecular basis of C/EBPa-dependent B cells to
macrophage transdifferentiation. Given the leukaemic
nature of this cell line, this model allows to test the inter-
action of additional alterations that may counteract or
accelerate lineage reprogramming, in a context similar
to several pathological processes.
Transdifferentiation by forced expression of a transcrip-
tion factor involves direct regulation of its target genes in
cooperation with elements of the epigenetic machinery
within chromatin. Most studies addressing epigenetic
changes associated with cell reprogramming have
focused on reprogramming towards pluripotency where
DNA methylation changes play a pivotal role (12). The
role of DNA methylation is best known in the context of
promoters, particularly those containing CpG islands,
where this modiﬁcation is generally associated with gene
repression (13). In reprogramming towards pluripotency,
DNA demethylation is essential to restore DNA methyla-
tion and expression patterns similar to those present
in embryonic stem (ES) cells (9,14). In this process,
activation-induced cytidine deaminase (AID) has been
demonstrated to be required for promoter demethylation
and induction of genes like OCT4 and NANOG (15).
However, there is emerging evidence for substantial
differences in DNA methylation between ES cells and
iPSCs (16–19). Recent data indicate that transcription
factor-mediated reprogramming to iPSCs result in
megabase-scale regions of aberrant methylation (20).
These ﬁndings highlight the importance of investigating
the speciﬁc contribution of different transcription
factors in the establishment of epigenetic patterns in
reprogramming experiments.
In the present study, we have investigated the acqui-
sition of DNA methylation changes during C/EBPa-
dependent B cell to macrophage transdifferentiation.
Unexpectedly, we found that C/EBPa-mediated transdif-
ferentiation of B cell into functional macrophages occurs
without detectable DNA methylation changes at the
promoter of key differentiation genes. High-throughput
analysis and the use of two different model systems
conﬁrmed that this process takes place in the absence
of signiﬁcant DNA methylation changes. Remarkably,
C/EBPa activates gene expression by binding to hyper-
methylated promoters and inducing changes in histone
modiﬁcations of macrophage associated genes. Our data
challenge the current perception of the signiﬁcance of
DNA methylation changes in cell lineage reprogramming
and suggests a hierarchy of epigenetic changes necessary
to ensure functional C/EBPa-induced B cell to macro-
phage reprogramming.
MATERIALS AND METHODS
Cells
Normal primary macrophages and pre-B cells were
derived from bone marrow as described elsewhere
(10). HAFTL cells are a foetal-liver-derived, Ha-ras-
oncogene-transformed mouse pre-B cell line (21) and
were provided by Dr B. Birnstein. RAW 264.7 cells are
a mouse leukaemic monocyte macrophage cell line (22)
and were provided by Dr D. Cox. C10 cells were previ-
ously developed (11) and consist of a clone derived
from HAFTL cells infected with a b-estradiol-inducible
viral system containing a fusion between C/EBPa and
the oestrogen hormone-binding domain (C/EBPaER).
Induction of reprogramming assays
C10 cells were grown in RPMI 1640 without phenol red
(Lonza) supplemented with 10% charcoal/dextran-treated
FBS (Hyclone) and 50mM 2-mercaptoethanol (GIBCO),
incubated at 37Ci n5 %C O 2. They were induced by
the addition of 100nM b-estradiol (Calbiochem) and
grown with 10nM IL-3 and CSF-1 (Peprotech). Control
cells were treated with 0.1% ethanol (solvent).
Reprogramming of primary pre-B cells was carried out
by transducing C/EBPa cloned in pMIG retrovirus
vector as previously reported (10). Cell-surface antigens
were stained with directly conjugated antibodies against
Mac-1 and CD19 (BD PharMingen). Cells were analyzed
with a FACSCanto ﬂow cytometer (BD Biosciences,
San Diego, CA, USA), via FlowJo software (Tree Star,
Ashland, OR, USA). FACS was also used to measure
forward and side scatter. For pulse-induction transdiffer-
entiation assays cells were washed thoroughly after 48h
and incubated with 10mM of the b-estradiol antagonist
ICI 182780 (Tocris Bioscience).
DNA methylation analysis
DNA methylation status was determined by sequencing
bisulﬁte-modiﬁed genomic DNA as described by
Herman et al. (23). For quantitative purposes, each
amplicon was cloned and between 15 and 20 clones were
sequenced as described in Javierre et al. (24). For each
gene, primers were designed using the Methyl Primer
Express v1.0 program (Applied Biosystems). Both
promoter CpG islands-containing genes and genes with
low CpG density promoters were analyzed. Classiﬁcation
was performed following algorithms by Wu et al. (25).
For promoter CpG island-containing genes, CpG island
shores were also analyzed (26). The primer sequences,
product lengths and annealing temperatures used for
bisulﬁte sequencing reactions are shown in Supplementary
Table S5.
MethylCAP-chip
MethylCAP, a technique based on capture of methylated
DNA with the MBD domain of MeCP2, was performed as
described (27,28) using MethylCAP kit (Diagenode). The
MBD-bound and input fractions were then analyzed by
qPCR with primers of genes previously analyzed (like
Cebpa, Dock8, Ebf1 and Pax5) to conﬁrm enrichment of
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then performed with both input and immunoprecipitated
fractions using the GenomePlex WGA ampliﬁcation Kit
(Sigma). Further conﬁrmation of the enrichment of
methylated in immunoprecipitated fractions was again
performed by qPCR of the aforementioned genes.
Three independent experiments were performed for
hybridization on mouse 385K promoter microarrays
(Nimblegen). Ten different samples were analyzed: ﬁve
were related to primary cells (pre-B cells, pre-B cells
infected with the C/EBPa retrovirus and induced with
b-estradiol for 0, 48 and 120h, and macrophages) and
ﬁve corresponding to the cell line-based system (HAFTL
B cells, C10 cells at 0, 48 and 120h after estradiol induc-
tion and RAW macrophages). In each case, competitive
hybridization was performed, in which input and the
MBD-bound fractions were, respectively, labelled with
Cy3 and Cy5. For each microarray hybridization, we
used the raw feature intensities to form log ratios and
denoted these with M, as done by others (29).
Microarray data analysis
Normalization. For each probe, the log2 ratio of the
MBD-bound and the input (designated as M) was
computed. To allow array comparison we performed a
vsn normalization of the probes (30) using the limma
package (31). No relevant changes were observed if differ-
ent normalization methods (such as ‘median-centring
and quantile normalization’) were used.
Gene selection by probes. Probes were ﬁrst mapped to the
mm9 version of the Mus musculus genome; those probes
that were not mapped near a transcriptions starting site
(TSS) were discarded. This region near the TSS was
deﬁned as the 2000 to +500bp region (32) however
more constrained deﬁnitions of a TSS are possible (33).
For each gene an M value was computed as the average
value for all the probes mapped to its TSS. Only those
genes with at least three probes mapped to their TSS
were considered in the genome wide analysis.
Gene selection by differential methylation. We considered
for each gene the difference of the minimum and
maximum value within primary cells (PC) and cell lines
(CL), denotes, respectively, by PCmaxM and CLmaxM.
For a given threshold (th) a gene was selected in PC
(CL) experiment if PCmaxM<th (CLmaxM<th). We
computed the number of selected genes for different
thresholds (Figure 2A). For any given threshold most
genes considered differentially methylated in PC were dif-
ferentially methylated in CL. To set a restrictive deﬁnition
of differential methylation a threshold of 0.6 was selected.
However for different values of threshold we observed
similar results, so our conclusions are fairly robust.
Number of differentially (diff) methylated genes in PC
(diffPC) and CL (diffCL) are 2009 and 1533, respectively.
The intersection of diffPC and diffCL is 806 genes.
Comparison of DNA methylation data with Affymetrix
data. To compare DNA methylation level (M values)
versus Affymetrix expression data (11) we ﬁrst performed
normalization of the raw Affymetrix expression data by
Robust Multi-chip Analysis (RMA) (34) via the Affy
package. Normalized log2 scaled values were then
averaged, and ratios were calculated to isolate probes
showing an at least 2-fold change.
Quantitative RT-PCR expression analyses
Total RNA was isolated by using TRIzol Reagent
(Invitrogen Co.) according to the manufacturer’s rec-
ommendations, and cDNA was produced with the
SuperScript II Reverse Transcriptase (Invitrogen
Co.). Quantitative Real-Time PCR (Q-RT-PCR) was per-
formed on a LightCycler 480 II System using LightCycler
480 SYBR Green Mix (Roche). Reactions were carried
out in triplicates and Q-RT-PCR data was analyzed using
the Standard Curve Method. Primer sequences are
shown in Supplementary Table S5.
Immunoprecipitation and chromatin immunoprecipitation
assays
Immunoprecipitation was performed by standard pro-
cedures in HAFTL, RAW and C10 cells at 0, 48 and
120h after b-estradiol treatment. Cellular extracts were
prepared in 50mM Tris-HCl, pH 7.5, 1mM EDTA,
150mM NaCl, 1% Triton–X-100 and protease cocktail
inhibitors (Complete, Roche Molecular Biochemicals).
For chromatin immunoprecipitation (ChIP) assays, C10
cells treated with b-estradiol for 0, 48 and 120h, HAFTL,
and RAW cells were crosslinked with 1% formaldehyde
and subjected to immunoprecipitation after sonication.
ChIP experiments were performed as described (35). The
following antibodies were used: Anti-H3 (Abcam, ab
1791), Anti-AcH3 (K9/K14) (Diagenode, pAb-005-044),
Anti-3meK4H3 (Millipore, 17-614), Anti-3meK27H3
(Millipore, 07-449), Anti-C/EBPa (14AA) (Santa Cruz
Biotechnology, sc-61), Anti-p300 (N-15) (Santa Cruz
Biotechnology, sc-584), Anti-p300 (C-20) (Santa Cruz
Biotechnology, sc-585) and Anti-RNA polymerase II
CTD repeat YSPTSPS (phospho S5) (Abcam, ab5131).
Analysis was performed by real-time quantitative PCR.
Data are represented as the ratio between the ‘bound’
fraction of the histone modiﬁcation antibody to that of
the C-t histone H3 (total) antibody for histone marks, and
as the ratio between the bound fraction over the input for
transcription factors. Primer sequences are shown in
Supplementary Table S5. In some cases, the methylation
of DNA isolated from ChIP experiments was analyzed.
In those cases, DNA was pooled from a minimum of
ﬁve experiments and subjected to bisulﬁte modiﬁcation,
as described earlier.
Western blotting
Cellular extracts and samples from immunoprecipitation
experiments were electrophoresed and western blotted ac-
cording to standard procedures. The blots were developed
with the ECL detection kit (Amersham Pharmacia
Biotech). Anti-C/EBPa, and anti-p300 antibodies were
those listed earlier.
1956 Nucleic Acids Research, 2012,Vol.40, No. 5RESULTS
Key differentiation genes exhibit a differential DNA
methylation status in pre-B and macrophage cells
To investigate the existence of DNA methylation changes
in association with C/EBPa-mediated B cell to macro-
phage transdifferentiation, we ﬁrst mapped the DNA
methylation status of 45key genes relevant to B cell and
macrophage function (Supplementary Table S1) to select
those with signiﬁcant differences between B cells and
macrophages. For that, we examined both primary cells
and cell lines: mouse primary bone marrow derived pre-B
cells and macrophages and, alternatively, HAFTL B cells
and RAW 264.7 macrophages. The gene selection
included bona ﬁde markers of cell identity for the two
cell types, as well as genes with known expression
changes occurring during B cell to macrophage reprog-
ramming (11). We performed bisulﬁte genomic sequencing
in a 300- to 450-bp region around the transcription start
site (TSS) of the 45 genes, 30 of which contained CpG
islands and 15 contained promoters with low CpG
density (Supplementary Table S1). For 24 of the 45
genes, we found differential DNA methylation at CpG
sites near the TSS when comparing HAFTL B cells and
RAW macrophages (Supplementary Table S1). Cd19,
Pax5, Ikzf3 and other B cell-speciﬁc genes, were
methylated in RAW macrophages but not in HAFTL B
cells. Conversely, genes like Itgam, Cebpa, Dock8 and
other macrophage-associated genes, were methylated in
HAFTL cells but not in RAW cells (Supplementary
Table S1). Other genes, like Tcf3 (E2a), Mef2c, Fmr1
and Foxo1 (among the B cell-speciﬁc set), or Cebpb,
Evi2a and Emb (among the macrophage-speciﬁc group)
showed no differences (Supplementary Table S1). Both
HAFTL and the C/EBPa-inducible pre-B cell line C10
had virtually identical DNA methylation patterns for all
studied genes (not shown), indicating that HAFTL
cells remain an appropriate reference for C10 cells.
In contrast to the cell lines studied, primary B cells
and macrophages were devoid of DNA methylation for
the majority of genes listed earlier (Supplementary
Table S1). Only 5 of the 45 analyzed genes exhibited
relevant levels of DNA methylation, and of those only 4
(Mmp8, Igsf6, Tlr2 and Xdh) had a differential methyla-
tion status. The higher levels of promoter methylation
observed for HAFTL and RAW cells with respect to
primary B cells and macrophages are consistent with
previous ﬁndings by others. As mentioned, HAFTL and
RAW cells are both leukaemogenic (21,22). Data
generated by multiple groups have shown that a large
number of promoters can become de novo methylated at
early stages in tumourigenesis (33,36,37). Many of these
DNA methylation events occur at the promoter of genes
that are repressed in the normal primary tissue, including
macrophage-speciﬁc genes that are repressed in primary B
cells, and B-cell-speciﬁc genes repressed in macrophages.
It has also been reported that extended in vitro prolifer-
ation results in hypermethylation of differentiation genes
in a pattern reminiscent of that reported in primary
tumours (38). We therefore decided to monitor epigenetic
changes in C/EBPa-mediated B cell to macrophage
transdifferentiation in both systems.
B cell to macrophage transdifferentiation occurs in the
absence of DNA methylation changes at key
differentiation genes
To explore DNA methylation changes during B cell
to macrophage transdifferentiation we ﬁrst analyzed
C/EBPaER-expressing B C10 cells at three times during
reprogramming, by focusing on the 24 genes that display
differential DNA methylation between HAFTL B cells
and RAW macrophages (Supplementary Tables S1 and
Figure S1). We tested cells at 0h, immediately after the
addition of b-estradiol; at 48h, when the phenotype
has already become that of a macrophage-like cell and
reversion does not occur following b-estradiol depletion;
and at 120h, when the macrophage-like phenotype has
had time to fully stabilize. Unexpectedly, the DNA methy-
lation patterns for these genes in C10 cells did not change
during transdifferentiation and was identical for the
24 genes analyzed in C10-derived functional macro-
phages and uninduced C10 cells or HAFTL B cells
(Figure 1A–C). Thus, macrophage-associated genes
remained methylated in C10-derived macrophages and
conserved an identical methylation pattern to that
observed in HAFTL and unreprogrammed C10 B cells
(Figure 1A and C). Conversely, B cell-associated genes
that are not expressed either in RAW cells or in
reprogrammed cells, were only methylated in RAW cells,
and reprogrammed macrophages retained the unmethyl-
ated status present in HAFTL B cells (Figure 1B and C).
Similar results were obtained in transdifferentiation
experiments with primary cells since there were no
changes in DNA methylation during reprogramming for
the few candidate genes displaying differences between the
two parental primary cell types (Figure 1C and
Supplementary Figure S2B).
To check whether DNA methylation changes may be
acquired over longer time periods, after the cell popula-
tion had divided at least once (11) we also analyzed the
DNA methylation patterns of some of the genes at 7, 10,
15 and 30 days after addition of b-estradiol to C10 cells,
much time after the phenotype is no longer reversible.
Neither acquisition nor loss of DNA methylation was
observed for any of the genes (Supplementary Figure S3).
The lack of signiﬁcant observable changes may be
associated to absence of changes in expression levels
of DNA methyltransferases (DNMTs) or activation
induced cytidine deaminase (AID). To test this possibility,
we measured by qRT-PCR the levels of the three bona ﬁde
DNMTs, DNMT1, DNMT3a and DNMT3b, and of
AID. While Dnmt1 and Dnmt3b became ﬁrst down-
regulated and then slightly upregulated again, Dnmt3a
and Aid became upregulated after 48h before dropping
at 120h (Figure 1D).
It is generally assumed that transcriptionally relevant
CpG methylation occurs in promoters and most methyla-
tion studies have therefore focused on CpG island-
containing promoters (13). However, it has recently been
reported that DNA methylation changes at CpG island
Nucleic Acids Research,2012, Vol.40, No. 5 1957Figure 1. Transdifferentiation of B cells to macrophages occurs without DNA methylation changes in key genes. (A) Selected examples of bisulﬁte
genomic sequencing at the promoter CpG islands and CpG island shores of two macrophage-speciﬁc genes in parental HAFTL B cells, RAW
macrophages, and C/EBPaER-expressing B C10 cells (derived from HAFTL) at 0h (after C/EBPa induction) and reprogrammed into functional
macrophages (48 and 120h). Percentage of DNA methylation is represented by red bars and CpG site number included in the analysis is indicated at
the bottom. The two analyzed regions are CpG island (right panel, black bar) and CpG island shore (left panel, grey bar). (B) Selected examples of
bisulﬁte genomic sequencing at the promoter CpG islands and CpG island shores of two B cell-speciﬁc genes in parental HAFTL and RAW cells and
C10 cells at 0h and fully reprogrammed into functional macrophages (48 and 120h). The two analyzed regions are CpG islands (right panel, black
bar) and CpG island shores (left panel, grey bar). (C) Heatmap of DNA methylation data for 13 macrophage-speciﬁc genes (top) and
(continued)
1958 Nucleic Acids Research, 2012,Vol.40, No. 5shores, CpG containing regions adjacent to CpG islands
up to 2kb distant, can also correlate with changes in gene
expression (26). We therefore analyzed the DNA methy-
lation status of CpG island shores for some of the CpG
island-containing promoters included in our study. We
found that the methylation status at CpG island shores
did not strictly correlate with expression status in HAFTL
or RAW cells. For instance, the CpG island shore in
Cebpa was methylated both in HAFTL and RAW cells
(Figure 1A). In other cases, like Dock8 or Pax5, their CpG
island shores exhibit identical methylation patterns to
their adjacent CpG islands in HAFTL and RAW cells
(Figure 1A and B). Importantly however no changes in
the CpG island shores were observed during transdiffer-
entiation in any of the genes analyzed (Figure 1A and B).
We also checked the DNA methylation status of the gene
bodies, intragenic sequences >500bp downstream of the
transcription start sites, which has also been shown to be
correlated with gene activity (39,40). Similarly to the
results obtained for CpG islands and CpG island shores
no changes were observed during transdifferentiation for
the genes studied (Supplementary Figure S4).
The absence of DNA methylation changes was
unexpected considering that many lineage-speciﬁc genes
exhibit 10- to 100-fold expression changes during the
transdifferentiation process (11). It was also surprising
that activated macrophage-speciﬁc genes retain hyper-
methylated promoters, given the well established relation-
ship between promoter CpG methylation and gene
repression and that promoter hypermethylation of some
of the genes studied here, like Cebpa or Cebpd, are
associated with loss of expression (41,42).
To investigate whether DNA methylation inﬂuences the
expression status of these genes in the cell types studied,
we cultured HAFTL, C10 and RAW cells in the presence
of the DNA demethylating agent 5-azadC to measure the
effect of pharmacologically induced DNA demethylation
on the expression levels of these genes. We found
increased expression of all methylated genes, suggesting
that DNA methylation indeed helps to maintain their
lineage-speciﬁc repressed status in each corresponding
situation (Supplementary Figure S5). However the levels
obtained following pharmacological demethylation did
not reach the ones present in the cell type where these
genes are normally expressed indicating the existence
of additional factors regulating their expression
(Supplementary Figure S5B).
High-throughput analysis conﬁrms absence of signiﬁcant
changes in DNA methylation during pre-B cell to
macrophage transdifferentiation
To check the generality of our conclusions regarding the
absence of DNA methylation changes, we performed
high-throughput methylation analysis in C/EBPa
mediated transdifferentiation in both the C10- and
primary cell-based systems. To this end, we performed
methylCAP (27,28) associated with hybridization on
mouse 385K promoter microarrays for the 10 different
samples previously studied. Preliminary analysis of
methylCAP samples by qPCR of previously studied
lineage-speciﬁc genes conﬁrmed enrichment of methylated
DNA in the MBD-bound fraction as well as absence of
changes in those genes during reprogramming (Figure 1E).
Following hybridization, we mapped probes to the
genome and selected those within the 2000 to +500bp
region around the transcription start site (32). A compari-
son of the DNA methylation data (obtained as the log
ratio of the raw intensities, and designated as M) for
pre-B cells and macrophages revealed that, at any given
threshold, a high proportion of the genes that are differ-
entially methylated between HAFTL pre-B cells and
RAW macrophages are also differentially methylated
between primary pre-B cells and macrophages
(Figure 2A), highlighting the similarities between C10
cells and primary pre-B cells. To unify comparisons of
potential acquisition of DNA methylation changes of
both C10 cells and primary cells we performed all com-
parisons with respect to primary macrophages (although
comparisons of C10 cells against RAW macrophages were
also made and yielded similar results, Supplementary
Figure S6). We conﬁrmed that candidate genes previously
characterized by bisulﬁte sequencing were also differen-
tially methylated between control pre-B cells and
macrophages and showed no changes in methylation
during transdifferentiation (Supplementary Figure S6A).
Analysis of the data showed that 1533 genes are differen-
tially methylated between HAFTL and macrophages,
whereas 2009 are differentially methylated between
primary pre-B cells and macrophages (both at a threshold
of 0.6) (Supplementary Table S3). A total of 806 genes
differentially methylated between primary B cells and
macrophages were common between the two systems
(Figure 2B).
Our analysis revealed that neither C10 cells nor primary
B cells undergo any signiﬁcant DNA methylation
changes during C/EBPa-mediated transdifferentiation.
Hierarchical clustering of the two sets of samples
reinforced the notion that reprogrammed macrophages
(at 48 and 120h) in both primary cells and the
C10-based system have virtually identical DNA methyla-
tion patterns to primary pre-B cells and HAFTL cells,
respectively, and have not undergone changes that
would make their DNA methylation proﬁles more
similar to the ones present in control macrophages
(primary macrophages and RAW cells). This is illustrated
by the heatmap and barplot generated after hierarchical
Figure 1. Continued
11 B cell-speciﬁc genes (bottom) in HAFTL and RAW cells and C10 cells at three times during b-estradiol-induced reprogramming (0, 48 and 120h).
Heatmap of DNA methylation data including the four macrophage-speciﬁc genes that are differentially methylated between primary B cells and
macrophages are also included at the bottom. The number of CpG sites analyzed for each gene is indicated on the right of the heatmap. Values are in
Supplementary Table S2. (D) qRT-PCR kinetics of expression of DNA methyltransferases (Dnmt1, Dnmt3a and Dnmt3b) and activation induced
deaminase (Aid). H and R, respectively, designate HAFTL and RAW cells. (E) qPCR analysis of MBD-bound (methylated) fractions obtained from
MethylCAP experiments with HAFTL and RAW cells and C10 cells at 0, 48 and 120h for two macrophage-speciﬁc and two B-cell-speciﬁc genes.
Nucleic Acids Research,2012, Vol.40, No. 5 1959clustering analysis (Figure 2C), where only differentially
methylated genes were considered in each case. Among the
genes that are differentially methylated between B cells
and macrophages and that do not undergo methylation
changes during transdifferentiation there are important
regulators of cell cycle, differentiation and identity
(Supplementary Table S4). For instance, these lists
include Hox (Hoxb5, Hoxb8, Hoxc9, Hoxd10, Hoxd11,
Figure 2. High-throughput DNA methylation analysis shows no signiﬁcant changes during C/EBPa-mediated transdifferentiation. (A) Plot showing
the proportion of genes that are differentially methylated depending on the selection threshold used. Data corresponds to the C10-based system,
primary cells and the intersection of both sets of data. (B) Venn diagram showing the overlap of differentially methylated genes between the primary
cells and C10-based cell system. (C) Heatmap and barplot representing M (log ratio raw intensities between immunoprecipitated DNA and input in
MethylCAP experiments) for C10 cells at 0, 48 and 120h after b-estradiol addition, primary pre-B cells, infected with C/EBPa retrovirus and
b-estradiol induced for 0, 48 and 120h, as well as HAFTL pre-B cells and primary macrophages. (D) Plots representing M versus Affymetrix
expression data (11) for C10 at 0 and 48h after b-estradiol addition (left and centre panels). The difference between two different situations:
diff(C1048h–C10 0h) for both M and expression is also represented (right panel).
1960 Nucleic Acids Research, 2012,Vol.40, No. 5Hoxd12) and Fox (Foxc1, Foxc2, Foxd3, Foxf1a, Foxg1,
Foxd1, Foxq1) genes, which play crucial roles in differen-
tiation and development, interleukins (Il11, Il12b, Il17a,
Il18r1, etc) as well as macrophage- and lymphoid-speciﬁc
genes. We performed t-test to compare the M values of
cells at 48 and 120h with respect to B cells in both primary
and cell lines and therefore to investigate the potential
existence of small sets of genes that may undergo DNA
methylation changes during transdifferentiation, however
not signiﬁcant results were produced (all genes had an
FDR>0.1), conﬁrming our previous conclusion.
Our data not only suggest that DNA methylation
changes are dispensable during C/EBPa-mediated repro-
gramming but also point out a change in the relationship
between DNA methylation and expression levels in
C/EBPa-mediated transdifferentiation. To test this
hypothesis we compared high-throughput methylation
data of C10 cells at 0 and 48h after estradiol addition
with their corresponding Affymetrix expression data (11)
(accession number GSE17316). Scatter plots where DNA
methylation is represented against expression data
indicate the existence of a general inverse correlation
between methylation and expression levels (Figure 2D,
left panel, P<0.001, r=0.241; centre panel, P<0.001,
r=0.236). However, when looking at the transition
between C10 cells at 0 (functional pre-B cells) and
48h (functional macrophages) (represented as diff
[C1048hC100h]), we observed that during transdiffer-
entiation many genes undergo changes in expression
without a change in DNA methylation and Pearson
correlation (P<0.01) showed that no relation between
transcription changes and DNA methylation changes
exists during this process (Figure 2D, right). Identical
results were obtained by looking at the genes obtained
from the separate analysis of cell lines (Supplementary
Figure S6C).
Histone H3 modiﬁcations accompany gene expression
changes during B cell to macrophage transdifferentiation
The lack of DNA methylation changes during B cell to
macrophage transdifferentiation in genes that undergo
expression changes suggests that alternative epigenetic
factors, like histone modiﬁcations, have a stronger associ-
ation with the expression status of these genes, at least
in our model system. To address this issue we chose
ﬁve macrophage-speciﬁc genes (Itgam, Sfpi1, Cd14 and
Dock8) and four B cell-speciﬁc genes (Cd19, Pax5, Ebf1
and Bcl11a), for which we found differential promoter
DNA methylation between HAFTL and RAW cells
(Supplementary Table S1). These genes undergo changes
in transcription as expected during transdifferentiation
(Supplementary Figure S7; (10,11). We then performed
ChIP assays for three histone H3 modiﬁcations
well-characterized for their localization at promoters
and functional association with gene expression status:
histone H3 K4 trimethylation (H3K4me3) and acetylation
(H3K9acK14ac), associated with active transcription, and
histone H3 K27 trimethylation (H3K27me3), associated
with gene repression (43–45). We analyzed the proﬁle of
these histone modiﬁcation marks at the promoter of
the two groups of genes studied in a region near the
TSS overlapping with the region analyzed for DNA
methylation (Figure 3, top).
We observed that active histone modiﬁcations, histone
H3 K9/K14 acetylation and K4 trimethylation, correlated
with an increase in gene expression of macrophage-speciﬁc
genes (Figure 3A). For B cell-associated genes, H3
K9/K14 acetylation and K4 trimethylation decreased in
parallel with their expression during transdifferentiation
(Figure 3B). Likewise, there was a correlation between
gene expression and histone H3 K4 trimethylation and
K9/K14 acetylation in pre-B cells and macrophages.
For H3K27me3, we observed the opposite behaviour, as
it was absent at the promoter of B-cell-speciﬁc genes in
pre-B cells and present in macrophages. In macrophage-
associated genes H3K27me3 was present in HAFTL and
absent in RAW cells. Interestingly, we did not observe an
increase in H3K27me3 H3 in B cell-associated genes
during reprogramming (Figure 3B, bottom). However,
for macrophage-speciﬁc genes a loss of H3K27me3 did
occur in parallel with an increase in gene expression
(Figure 3A, bottom), except for Sfpi1, which is expressed
in both HAFTL and RAW cells.
We then wondered whether changes in histone modiﬁ-
cations persist if the induction of CEBP/a is turned off at
48h or, in other words, if histone modiﬁcations return
to the pre-B cell state in the absence of the inducer. As
described in our previous study (11), transdifferentiation is
no longer reversible after 48h. We therefore performed
pulse-induction transdifferentiation assays cells where
b-estradiol was washed out at 48 and investigated the
histone H3 modiﬁcation proﬁle at 120h, when the pheno-
type should have stabilized. No differences were found
with respect to standard trandifferentiation experiments
(Supplementary Figure S8), supporting the notion of the
stability of this histone modiﬁcation proﬁle associated
with altered DNA methylation patterns in transdiffer-
entiated macrophages.
C/EBPa binds the methylated promoter of
macrophage-speciﬁc genes and recruits p300 regardless
of their DNA methylation status
C/EBPa-mediated transdifferentiation involves expression
changes in several thousand genes (11). A signiﬁcant
proportion of these changes is likely caused by direct
C/EBPa binding and regulation, although the full range
of target genes is currently unknown. Some of the
macrophage-speciﬁc genes included in our study, like
Cd14, Sfpi1 or Cepba, are known direct C/EBPa targets
(46–48) and sequence inspection of genes like Itgam or
Dock8 showed the presence of C/EBPa binding sites (49)
near their respective transcription start sites. We used
ChIP assays to investigate C/EBPa binding at the Cd14,
Itgam, Sfpi1, Dock8 and Cebpa promoters in C10 cells
during transdifferentiation. We also tested the promoter
of the pre-B cell-speciﬁc gene Ebf1. Our analysis
showed speciﬁc binding of C/EBPa to all the above
macrophage-speciﬁc genes in reprogrammed cells (48
and 120 h) but not to Ebf1 (Figure 4A). C/EBPa associ-
ation appeared to occur in reprogrammed macrophages,
Nucleic Acids Research,2012, Vol.40, No. 5 1961Figure 3. Changes in the histone modiﬁcation proﬁle accompany changes in the expression status of key genes. Quantitative ChIP assays show
changes in the levels of H3K9acK14ac and H3K4me3, as active marks, and H3K27me3, as a repressive mark, in both macrophage-speciﬁc genes
(A) and B cell-speciﬁc genes (B). HAFTL pre-B cells (H) and RAW macrophages (R) are used as controls and C10 cells at 0h and fully
reprogrammed into functional macrophages (48 and 120h). In all cases, data is normalized with respect to the values in HAFTL cells. On top
of each gene, a scheme depicting the sequence covered for DNA methylation analysis (black bar) and ChIP analysis (grey bar), in relation with the
transcription start site (arrow) is shown.
1962 Nucleic Acids Research, 2012,Vol.40, No. 5Figure 4. C/EBPa associates with P300 and with macrophage-and B cell-speciﬁc genes during transdifferentiation. (A) Quantitative ChIP assays
showing the binding of C/EBPa to the promoter of ﬁve macrophage-speciﬁc genes. Ebf1 is used as an example of B-cell speciﬁc genes. HAFTL pre-B
cells (H) and RAW macrophages (R) are used as controls. (B) Quantitative ChIP assays showing the binding of RNApol II to the promoter of ﬁve
macrophage-speciﬁc genes. Ebf1 is used as an example of B-cell speciﬁc genes. HAFTL pre-B cells (H) and RAW macrophages (R) are shown as
controls. (C) C/EBPa and p300 are associated in C10 cells, at 0, 48 and 120h following transdifferentiation induction, as demonstrated by
immunoprecipitation. (D) Quantitative ChIP assays showing the binding of p300 to the promoter of ﬁve macrophage-speciﬁc genes. Ebf1 is used
as an example of B-cell-speciﬁc genes. HAFTL pre-B cells (H) and RAW macrophages (R) are used as controls.
Nucleic Acids Research,2012, Vol.40, No. 5 1963in which these promoters are methylated, at comparable
levels to the ones observed in RAW macrophages, where
these promoters are unmethylated. Interestingly, methyla-
tion at these promoters does not interfere with the associ-
ation of the active form of the RNA Pol II, as
demonstrated by ChIP assays (Figure 4B).
In addition, it has been shown that C/EBPa, as well as
other C/EBP family members, can recruit co-activators
such as p300, a bona ﬁde histone acetyltransferase
(50,51). Therefore, we investigated whether C/EBPa can
directly associate with, and recruit p300 to the promoter
of some of the genes studied. To this end, we performed
immunoprecipitation experiments in C10 cells at 0, 48 and
120h following estradiol addition. We conﬁrmed that
p300 associates with C/EBPa in C10 cells (Figure 4C).
We then performed ChIP experiments with p300 in C10
cells following reprogramming induction, in parallel with
HAFTL B cells and macrophages. We found increased
and speciﬁc binding of p300 to the promoter of some of
the macrophage-speciﬁc genes during transdifferentiation
(Figure 4D), although the proﬁle of association was
slightly different to the one observed for C/EBPa.I n
fact, we observed that the B cell-speciﬁc gene Ebf1
shows a gradual decrease in p300 association (Figure
4C), suggesting that additional factors are involved in
eliciting changes in the recruitment of p300 histone
acetyltransferase and other histone modifying enzymes.
Uncoupling between DNA methylation and histone H3
modiﬁcations and C/EBPa binding during B cell to
macrophage transdifferentiation
The above results suggest that C/EBPa and RNA Pol II
associate the promoters of macrophages-speciﬁc genes
without sensing or inducing a modiﬁcation of the
DNA methylation status. They also suggest that during
C/EBPa-mediated B cell to macrophage transdiffer-
entiation the DNA methylation status of the genes
whose expression changes are at least partially uncoupled
from their histone modiﬁcation status. We therefore
decided to assess whether histone H3 K9/K14 acetylation
and K4 trimethylation, as well as C/EBPa and RNA
Pol II binding, were associated with macrophage-speciﬁc
genes that remain methylated state in reprogrammed
C10 macrophages. To this end, we performed bisulﬁte
sequencing of DNA isolated from chromatin immunopre-
cipitation experiments using H3K4me3, H3K9acK14ac
and C/EBPa antibodies (Figure 5A). Comparison of the
DNA methylation status of the DNA associated with
H3K4me3, H3K9acK14ac, C/EBPa and RNA Pol II in
four macrophage-associated genes (Itgam, Cebpa, Cd14
and Dock8) in both reprogrammed macrophages and
RAW cells showed that the DNA methylation status
of these genes and the two histone H3 modiﬁcations and
C/EBPa and Pol II binding are uncoupled (Figure 5B).
The absence of methylation changes at any CpG sites in
the DNA fraction associated with C/EBPa, RNA Pol II or
H3K4me3, H3K9acK14ac was conﬁrmed by looking at
the methylation proﬁles throughout the entire sequence
(an example is shown in Figure 5C).
DISCUSSION
Our results provide evidence that C/EBPa-induced B cell
to macrophage transdifferentiation occurs without sub-
stantial DNA methylation changes. In contrast, C/EBPa
is able to induce changes in active and repressive histone
H3 modiﬁcations at the promoters of key differentiation
genes. The ﬁrst implication of our ﬁndings is that
DNA methylation differences between control and
reprogrammed macrophages, that retain the methylation
proﬁle of pre-B cells, do not seem to be functionally
relevant, since both sets of macrophages are functionally
indistinguishable (10,11). This ﬁnding challenges our
general perception about the role of promoter methylation
in gene expression. Thus, among the genes studied in
detail herein, promoter DNA methylation-dependent
gene silencing has been demonstrated for Pax5, Ebf1,
Bcl11a or Cebpa for normal and leukaemic haemato-
poietic cells (41,42). Together with our own results
with DNA demethylating agents these data at ﬁrst
sight indicate that DNA methylation inﬂuences their
expression. However, bisulﬁte genomic sequencing of
macrophage-speciﬁc genes and high-throughput DNA
methylation analysis in reprogrammed macrophages
clearly shows that some of these genes remain highly
methylated at their promoters in a situation where high
expression levels can also be detected (11). The result is
independent of the model system (primary B cells,
HAFTL-based cell line) used to test C/EBPa-induced
transdifferentiation, although the number of hypermethyl-
ated genes is larger in the C10 system given its leukaemic
nature. However, a high proportion of genes that are
differentially methylated between pre-B cells and
macrophages in primary cells are also represented in the
C10-based system, highlighting the similarities between
the two models. Our results suggest that additional
factors, such as active histone modiﬁcations, are able
to overcome the repressive effect of DNA methyla-
tion in macrophage-speciﬁc genes in reprogrammed
macrophages.
Our data contrast with the results obtained for
transcription factor-mediated reprogramming systems
for the generation of iPSCs. Several studies have
recently addressed the issue of DNA methylation
changes during reprogramming towards pluripotency of
somatic cell types, using nuclear transfer or OCT4,
SOX2, KLF4 and MYC expression (9,14,16–19,52).
Studies comparing the functional and molecular
properties of resulting iPSCs and ES cells showed that
their expression and DNA methylation patterns
were highly similar (9,14). For instance, transcription
factor-induced reprogramming of ﬁbroblasts into iPSCs
resulted in demethylation of the Nanog and Oct4
promoters to a similar extent as present in ES cells, in
contrast to their highly methylated status in ﬁbroblasts
(9). In contrast, cells trapped in partially reprogrammed
pluripotent states failed in activating pluripotency genes
that were hypermethylated in the cell type of origin (14).
In all the systems studied, DNA demethylation appears to
play a critical role during reprogramming although the
extent of ressemblance in methylation patterns between
1964 Nucleic Acids Research, 2012,Vol.40, No. 5iPSCs and ES cells is variable depending on the strategy
followed in the generation of iPSCs. Among different
strategies, transcription factor-dependent reprogramming
differs not only in the dynamics of demethylation with
respect to nuclear transfer methods (14) but also in its
extent (18,19). In fact, detailed transcriptional and epigen-
etic comparison between transcription factor-obtained
iPSCs and ES cells have shown that iPSCs retain
residual DNA methylation signatures characteristic of
the somatic tissues of origin (16,19). In line with this,
our model system, in which cell lineage conversion is
achieved by the ectopic expression of a single transcription
factor, represents the most extreme example of residual
DNA methylation characteristic of the cell type of
origin. In fact, our analysis reveals the absence of substan-
tial promoter CpG methylation changes. Moreover,
detailed analysis of selected genes indicates that neither
promoters (both CpG island-containing or with low
CpG density) nor CpG island shores of any of the genes
studied undergo DNA methylation changes. However,
the genome-wide assays used here would not detect
single CpG demethylation events that might be occurring
within a sea of methylated residues. It also remains an
open possibility that alternative pathways to demethyl-
ation for macrophage-speciﬁc genes may take place,
such as oxidation of 5-methylcytosine (5meC) by the
recently described TET family of 5meC hydroxylases
(53,54). In fact we have obtained recent evidence that
supports this possibility (our unpublished data). Finally,
it is possible that other transcription factor-induced cell
lineage reprogramming systems will show different
outcomes with respect to the type and extent of DNA
methylation changes.
Another implication of the absence of DNA methyla-
tion changes in our system is the ability of C/EBPa to
efﬁciently induce changes in the expression of its target
Figure 5. Combination of ChIP analysis and bisulﬁte sequencing of B cell-speciﬁc and macrophage genes shows uncoupling of histone modiﬁcation
marks and DNA methylation status for reprogrammed C10 cells. (A) Scheme depicting the rationale for ChIP-BS experiments, where DNA
methylation status of the DNA fraction bound to a speciﬁc histone modiﬁcation or transcription factors is determined. (B) Five heatmaps show
the DNA methylation status (as assessed by bisulﬁte genomic sequencing of multiple clones) of ﬁve macrophage-speciﬁc genes associated with
H3K9acK14ac, H3K4me3, C/EBPa and RNA pol II in C10 reprogrammed macrophages (at 48 and 120h) and RAW macrophages. (C) An example
of the results obtained from ChIP-BS experiments where the proﬁles of the Cebpa promoter CpG island associated with H3K9acK14ac, H3K4me3,
C/EBPa and RNA pol II are compared for reprogrammed macrophages and RAW macrophages. (D) Schematic representation focusing on the
different epigenetic proﬁles observed for the two different sets of macrophages: those resulting from C/EBPa-dependent transdifferentiation of
C10 cells and RAW cells. Histone octamers are represented by grey circles. DNA is represented as a red line in which only methylated CpG
dinucleotides are shown (as red circles). Histone tails are lines protruding from octamers, where H3K9acK14ac, and H3K4me3 are indicated. Loss of
these two marks is indicated by absence of the protruding lines. The arrows indicate transcription of macrophage-speciﬁc genes.
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status at their promoters (CpG island shores and gene
bodies). Previous reports have shown that CpG methyla-
tion can directly interfere with transcription factor
binding. For instance, the transcription factor UBF, a
single methylated CpG site inhibits binding to nucleosom-
al rDNA (55). The explanation is that CpG methylation
either directly interferes with transcription factor binding
or affects the local chromatin structure, thus indirectly
interfering with binding. In view of these data the ability
of C/EBPa to bind to highly methylated macrophage-
speciﬁc promoters is remarkable although this might be
explained by the fact that its canonical binding site
does not contain any CG (49).
The absence of DNA methylation changes at
C/EBPa-target genes suggests that C/EBPa is neither
able to directly recruit DNMTs (or demethylating
activities like AID) nor facilitates the recruitment of
these enzymes, at least during the time period that leads
to the generation of functional macrophages. In contrast,
C/EBPa can associate with p300 [(50,51) and this study],
as well as other histone modiﬁcation enzymes, including
CREB-binding protein (CBP) and histone deacetylase 1
(HDAC1) (56,57). It is possible that the association with
these histone modiﬁcation enzymes mediates the recruit-
ment of additional enzymes, such as histone H3 K4 or
K27 methyltransferases.
In contrast to the apparent absence of changes in DNA
methylation, histone H3 K9/K14 acetylation and K4 and
K27 trimethylation were found to accompany changes in
expression during reprogramming of the genes studied.
The only exception is H3 K27me3 in the B-cell-speciﬁc
genes Cd19, Pax5, Ebf1 and Bcl11a. Multiple reports
have demonstrated that H3 K27me3 and DNA methyla-
tion are often associated (36,58). Binding of EZH2-
containing Polycomb-group (PcG) complex, that has H3
K27me3 catalytic activity, shows correlation with genes
that become hypermethylated in cancer (33,36,37). Since
B-cell-speciﬁc genes do not become hypermethylated
during B cell to macrophage reprogramming, we can
speculate whether the absence of both marks at the
promoters of these genes is associated. Interestingly, the
requirement of PcG complexes for efﬁcient reprogram-
ming towards pluripotency, where DNA methylation
changes are essential, has recently been demonstrated (59).
A remarkable implication of our ﬁndings is that DNA
methylation and activating histone H3 modiﬁcations
are apparently uncoupled in our system. For both B
cell-speciﬁc and macrophage-associated genes, we ﬁnd
that two different DNA methylation states for reprog-
rammed macrophages and the RAW macrophage
cell line occur in association with the same histone H3
modiﬁcation and expression pattern (Figure 5C). In
these two observed situations, histone modiﬁcations
better correlate with gene expression than DNA methyla-
tion in reprogrammed macrophages. Our data support the
notion of a hierarchy between different epigenetic marks
at the promoter of macrophage associated genes where
H3K9acK14ac and H3H3 K24me3 overimpose their
functional effects over the DNA methylation status of
these genes, particularly in the case of macrophage-speciﬁc
genes that remain hypermethylated and where the high
levels of expression are associated with active histone
H3 marks.
In summary, our ﬁndings not only provide insights
about the extent and hierarchy of epigenetic events
during B cell to macrophage reprogramming but also
highlight the importance in the development of
improved reprogramming strategies, such as alternative
combinations of factors for the faithful generation of
desired new cell types.
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